YOLFTbeta
NU

Nutex Investments PLC

NUTEX · BUD · Healthcare / Drug Manufacturers - Specialty & Generic

12.30HUF+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close12.30
Open12.30
Day Range12.30 – 12.30
52-Week Range10.30 – 17.30
Volume100
Market Cap1.88B
P/E (TTM)1.81
Forward P/E0.00
EPS6.08
Dividend Yield0.00%
Beta1.01
50-Day Avg12.34
200-Day Avg13.63

About

NUTEX Investments Public Limited Company provides health preserving, health promotion, nutritional supplement, and cosmetic products in Hungary and internationally. It also engages in asset management. The company was formerly known as HUMET Trade, Research and Development Public Limited Company and changed its name to NUTEX Investments Public Limited Company in February 2011. The company was incorporated in 1996 and is based in Budapest, Hungary.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOGábor Csereklei
  • Employees0
  • HeadquartersCziráki u. 24-32, Budapest, Hungary, 1163, Hungary
  • Websitehttps://nutex.hu

Leadership

  • Gábor CserekleiCEO & Director

Financials

Income Statement

Currency: HUF2010-12-312011-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--4.13M750.00K450.00K450.00K450.00K450.00K450.00K450.00K
Growth (%)----81.84%-40.00%0.00%0.00%0.00%0.00%0.00%
Cost of Revenue--00000000
Gross Profit--4.13M750.00K450.00K450.00K450.00K450.00K450.00K450.00K
Gross Margin--100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Operating Expense--13.53M10.24M18.04M13.59M16.42M21.35M97.12M108.89M
Operating Income---9.40M-9.49M-17.59M-13.14M-15.97M-20.90M-96.67M-108.44M
Operating Margin---227.53%-1265.87%-3909.78%-2919.78%-3548.00%-4643.56%-21482.00%-24097.78%
EBITDA---4.88M-7.62M30.45M20.33M142.82M426.50M-96.57M-108.13M
EBITDA Margin---118.09%-1015.73%6766.44%4517.78%31738.44%94777.56%-21460.89%-24027.78%
Net Income---375.68M-8.01M26.09M12.69M133.53M171.12M423.41M494.17M
Net Income Margin---9096.42%-1068.40%5797.11%2819.33%29672.44%38027.56%94091.56%109815.78%
Interest Expense00382.28M02.85M6.70M3.93M248.44M0-
Interest Expense % of Total Revenue--9256.27%0.00%632.22%1488.89%873.11%55207.78%0.00%-

Balance Sheet

Currency: HUF2010-12-312011-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets--1.15B1.82B3.61B5.17B5.31B5.48B5.00B5.56B
Total Liabilities--25.39M2.85M4.57M4.96M10.04M8.76M42.42M35.72M
Total Equity--1.13B1.82B3.60B5.17B5.30B5.47B4.96B5.52B
Cash--323.36M733.11M2.79B3.89B2.79B2.15B1.91B2.26B

Cash Flow

Currency: HUF2010-12-312011-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-50.99M-50.99M-21.07M-50.99M75.86M-443.79M-1.18B-536.09M-122.08M256.33M
Investing Cash Flow-99.00K-99.00K--99.00K-575.00K-429.00K----
Financing Cash Flow460.84M460.84M-460.84M1.98B1.55B----
Capital Expenditure99.00K99.00K099.00K575.00K429.00K00174.00K407.00K
Free Cash Flow---21.07M-51.09M75.28M-444.22M-1.18B-536.09M-122.25M255.92M
FCF to OCF--100.00%100.19%99.24%100.10%100.00%100.00%100.14%99.84%

Earnings

Report DateSep 30, 2015Dec 31, 2015Mar 31, 2016Aug 31, 2016
EPS Estimate----
EPS Actual-8.9511.63-21.6612.35
Surprise----
Timing---After-hours

Key Statistics & Ratios

Market Cap1.88B
Enterprise Value-3.99B
Trailing P/E1.81
Forward P/E0.00
Price / Sales4185.15
Price / Book0.31
EPS6.08
Book Value35.57
Revenue (TTM)450.00K
Gross Profit (TTM)450.00K
EBITDA-63.76M
Profit Margin199213.33%
Operating Margin-35840.45%
Return on Equity15.89%
Return on Assets-0.71%
Shares Outstanding171.21M
Shares Float120.90M
Beta1.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20111×
10.00Jun 3, 2011

Stock Splits

  • Mar 3, 20111:100
  • Oct 1, 20021:10